Clinical trials
Clinical Trials clinical trials
Below are recruiting clinical trials clinical trials, each written for real people, not researchers. We’re tracking 1,079 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06727344Recruiting
ACL recovery with blood flow restriction therapy
This study tests whether adding blood flow restriction (gentle pressure applied to the upper leg during exercise) to standard treatment can help heal a completely torn ACL. If you have a full ACL tear and can speak Greek, you may be able to join.
NicosiaAges 18–40 - NCT06727409RecruitingPhase 4
Triple therapy for type 2 diabetes and kidney disease
This study tests whether adding a non-steroidal mineralocorticoid antagonist to your current type 2 diabetes and kidney disease medications (SGLT2i and ACEi/ARB) is cost-effective. It may help preserve kidney function and reduce heart risks.
Hong KongAges 18 years+ - NCT06732895RecruitingPhase 2
Weekly injection for teens with achondroplasia
This trial tests a weekly injection called navepegritide for adolescents aged 12-18 with achondroplasia (a common form of dwarfism). The goal is to see if it can safely improve growth. You must have a genetic confirmation of achondroplasia and a historical height measurement from the past 6 to 15 months.
MontrealAges 12–17 - NCT06736587RecruitingPhase 1
Safety study of DWP212525 in healthy adults
This trial studies a new drug (DWP212525) in healthy volunteers to see how safe it is and how the body processes it. If you are a generally healthy adult, you could help researchers learn about the drug's effects.
SeoulAges 19–55 - NCT06743425Recruiting
Remote ADHD monitoring program for children
This pilot study tests a remote monitoring program (RAMP) for children with ADHD who are starting or restarting stimulant medication. It aims to see if using a smartphone app to track symptoms helps providers and families manage care.
Jackson, MississippiAges 5–11 - NCT06746688RecruitingPhase 1
Safety study of ES2B-C001 for HER2-positive metastatic breast cancer
This trial tests a new drug called ES2B-C001, with or without an adjuvant, to see if it is safe for people with HER2-positive breast cancer that has spread and has not responded to previous treatments.
GrazAges 18 years+ - NCT06747091Recruiting
Ablation study for people with persistent atrial fibrillation
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Manhasset, New YorkAges 18–80 - NCT06750289RecruitingPhase 3
Testing benralizumab for uncontrolled eosinophilic asthma
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
Chandler, ArizonaAges 12–75 - NCT06754722Recruiting
EnergyPoints app for cancer-related fatigue
This trial tests an app called EnergyPoints that may help reduce fatigue in people who have or have had cancer. You would use the app and wear a Fitbit to track your activity.
New York, New YorkAges 18 years+ - NCT06754891RecruitingPhase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
Bengbu, AnhuiAges 18–75 - NCT06759649RecruitingPhase 1
Study of COM503 for advanced solid tumors
This trial tests a new drug called COM503 for people with advanced solid tumors that have not responded to or cannot be treated with standard therapies. It aims to see if the drug is safe and how well it works.
New Haven, ConnecticutAges 18 years+ - NCT06759753RecruitingPhase 2
Aleeto for acute ischemic stroke: a randomized trial
This trial tests a drug called Aleeto in people who have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) within the last 72 hours. It aims to see if Aleeto can improve recovery and reduce disability.
BeijingAges 30–80 - NCT06765941Recruiting
PTeye vs surgeon's eyes for parathyroid protection in thyroid surgery
This trial tests whether a device called PTeye helps surgeons better identify and protect the parathyroid glands during first-time total thyroid removal surgery, compared to relying on the surgeon's eyes alone.
Krakow, MałopolskaAges 18 years+ - NCT06767501Recruiting
Amnion graft for diabetic foot ulcers vs. standard care
This trial tests whether a special amnion membrane graft can help heal diabetic foot ulcers better than standard care alone. If you have a diabetic foot ulcer that hasn't healed after standard treatment, this study may offer a new option.
Roanoke, VirginiaAges 18 years+ - NCT06778447Recruiting
Disc injection for chronic low back pain
This study tests whether injecting a special disc material (nucleus pulposus allograft) into the damaged discs of your lower back can safely reduce pain and improve function. It's for people with long-term, moderate to severe low back pain from disc disease that hasn't gotten better with other treatments.
Napa, CaliforniaAges 22–85 - NCT06779617Recruiting
Early sepsis detection trial at University of Maryland hospitals
This trial tests a new early warning system (SEPSys and RESCUE scores) to spot sepsis before it gets serious. If you're an adult in a University of Maryland hospital without sepsis, the system may help your doctors act faster.
Baltimore, MarylandAges 18 years+ - NCT06781567RecruitingPhase 2
HG146 for advanced adenoid cystic carcinoma
This trial tests a new drug called HG146 for people with advanced adenoid cystic carcinoma that has progressed despite previous treatments. The goal is to see if HG146 can slow or stop the cancer from growing.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06786676RecruitingPhase 1
Safety study of AS-S603 in healthy volunteers
This trial tests a new drug called AS-S603 in healthy volunteers to see if it is safe and how the body processes it. It is an early-phase study for people of Korean or Caucasian background.
SeoulAges 19–85 - NCT06792214RecruitingPhase 4
Testing if antivirals prevent long-term heart problems after COVID-19
This study tests whether two antiviral medications, Paxlovid and Veklury (remdesivir), can reduce the risk of long-term heart and blood vessel problems after a COVID-19 infection. It is for adults recently hospitalized with COVID-19 who are not currently on oxygen therapy.
Kingston, OntarioAges 18 years+ - NCT06796764Recruiting
Breathing tube safety during endoscopy in people with obesity
This trial tests a special breathing tube to see if it can prevent low oxygen levels during sedated endoscopy in people with obesity. If you are scheduled for both an upper endoscopy and colonoscopy, this study may help make the procedure safer.
Hangzhou, ZhejiangAges 18–70 - NCT06795347Recruiting
Online parenting support for mothers with mental health challenges
This trial tests an online video coaching program (VIPP-SD) to help mothers with serious mental health conditions build a strong bond with their child. The goal is to improve the child's wellbeing and resilience. It compares the program to the usual support that families already receive.
Odense C, Region SyddanmarkAges 1–3 - NCT06795971Recruiting
Comparing oxygen methods for hypoxemic respiratory failure
This trial compares three ways of giving extra oxygen to people with low blood oxygen levels: a face mask with continuous pressure, a noninvasive ventilator, or high-flow oxygen through the nose. The goal is to see which method helps people avoid needing a breathing tube.
Nanjing, JiangsuAges 18 years+ - NCT06796686RecruitingPhase 1
HIV vaccine safety and immune response study for healthy adults
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
San Francisco, CaliforniaAges 18–55 - NCT06800261RecruitingPhase 1
Testing a new pneumonia vaccine for babies 2-23 months old
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
Jinan, ShandongAges 1 month–1.9 years
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical trials?
- Yes. Clin2 currently lists 1,079 recruiting clinical trials studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trials trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trials trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Clinical Competence
- Clinical High Risk for Psychosis (CHR)
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Decision Support
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.